Background: Profilins are dominant pan-allergens known to cause cross-sensitization, leading to clinical symptoms such as pollen-food syndrome. This study aimed to determine the T-cell response to Phl p 12 in profilin-sensitized patients, by measuring the prevalence, strength and cross-reactivity to clinically relevant profilins.
Methods: The release of Phl p allergens from pollen was determined by mass spectrometry and immunochemistry.
Background: Immunologically enhanced subcutaneous specific immunotherapy (SCIT) has been developed with a fast and simplified updosing phase containing equal parts of the house dust mites (HDM) Dermatophagoides pteronyssinus and Dermatophagoides farinae (Dermatophagoides mix) adsorbed on aluminum hydroxide.
Objective: To evaluate the tolerability and immunological impact of the updosing phase of this new allergen extract formulation.
Material And Methods: We performed a multicenter, open-label, single-arm, phase II/III clinical trial.